Research ArticleNEUROPHARMACOLOGY
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine
Mark J. Millan, Alain Gobert, Françoise Lejeune, Adrian Newman-Tancredi, Jean-Michel Rivet, Agnès Auclair and Jean-Louis Peglion
Journal of Pharmacology and Experimental Therapeutics August 2001, 298 (2) 565-580;
Mark J. Millan
Alain Gobert
Françoise Lejeune
Adrian Newman-Tancredi
Jean-Michel Rivet
Agnès Auclair
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 298, Issue 2
1 Aug 2001
Research ArticleNEUROPHARMACOLOGY
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine
Mark J. Millan, Alain Gobert, Françoise Lejeune, Adrian Newman-Tancredi, Jean-Michel Rivet, Agnès Auclair and Jean-Louis Peglion
Journal of Pharmacology and Experimental Therapeutics August 1, 2001, 298 (2) 565-580;
Research ArticleNEUROPHARMACOLOGY
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine
Mark J. Millan, Alain Gobert, Françoise Lejeune, Adrian Newman-Tancredi, Jean-Michel Rivet, Agnès Auclair and Jean-Louis Peglion
Journal of Pharmacology and Experimental Therapeutics August 1, 2001, 298 (2) 565-580;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement